Abstract: Cytokines regulate the immune reactions elicited by renal transplantation (RT). This study was designed to investigate the blood serum levels of IL-2, IL-6, IL-8 in 25 RT patients (10 female and 15 male, mean 5.4±2.7 yrs after RT) three times over a six-month period during standard immunosuppressive therapy with cyclosporine A, azathioprine and prednisolone. The levels of IL-2, IL-6 and IL-8 were tested with ELISA Quantikine Human Interleukin Immunoassay (R&D Systems, detection level 7,0.7 and 10 pg/cm 3 , respectively). There was no significant alternation of blood serum levels of IL-2, IL-6 and IL-8 in the study patients.
Introduction
Cytokines regulate immune response and the inflammatory reactions in parallel with numerous biological reactions. A number of cytokines are released in response to the variety of antigens, bacterial lipopolysaccharides, lectins [1] and mediate information processing among inflammatory cells; this is particularly relevant in the setting of renal transplantation (RT) [2] . Immune disorders are attributed to complex alternations of the reactivity of immune competent cells, phenotype alternations of immune receptors and cell surface adhesion antigens in the milieu of abnormal levels of immune mediators. The causative role of immune dysfunction after RT is driven by immune incompatibility and rejection of graft organ [3] . The transplantation drives immune reactions involving the recognition and active damage of the transplanted organ. It further involves specific immune response of immune competent cells. Immune abnormalities in patients with chronic renal failure is likely to be secondary and only in some patients it may be determined by a given HLA configuration. Relatively fast and appropriate normalization of immune function after RT demonstrates the lack of permanent immune abnormalities in chronic renal failure [4] [5] [6] . The assessment of cytokine mediators and their receptors is useful in the research of graft rejection mechanisms. Molecular techniques are able to provide the insight at transcriptional and translational levels of inflammatory cell processing of cytokines and cytokine receptors and respective biopsy materials. Another available option is the assessment of cytokine levels in tissues and peripheral blood serum. The assessment of the soluble receptors for IL-2 and IL-6 in systemic circulation and graft-derived fluids may be complicated with their increase due to both the infection and rejection reactions. Moreover, gene activation of IL-2 and IL-4 and the cytokine expression may occur before the first clinical symptoms of the graft rejection. Therefore, the assessment of cytokine levels in RT patients as means of early detection of rejection may be a clinically useful diagnostic tool. This study was therefore designed to investigate the levels of IL-2, IL-6 and IL-8 in patients after renal transplantation within three consecutive six month periods.
Material and Methods

Experimental Design
The experimental construct of the study included blood serum levels of IL-2, IL-6, IL-8 in 25 RT patients (10 female and 15 male, mean 5.4±2.7 yrs after RT), which were routinely monitored three times within a period of six-months. All subjects taking part in the experiment had gone under objective and projective tests. Laboratory tests were administered to the subjects for instance, C reactive protein, urea, and creatine in the serum. Conditions that determined whether or not the test was reliable enough to be used in the experiment included, but were not limited to, a lack of clinical and biochemical marks of transplant rejection. Additional criteria that pertained to all patients was the lack of smoking as a habitual routine. Patients who satisfied the requirements for being included in the study were consulted by a nephrologist, an ophthalmologist and a vascular surgeon in order to exclude micro and macroangiopathy ( Table 1) . Among the healthy individuals taking part in the study, no control group was created. The internal threat of mortality was not an issue. All patients who committed themselves to the experiment had participated fully throughout the entire study. Patients underwent immunosuppressive therapy with cyclosporine A (100-225 mg daily), azathioprine (50-100 mg daily) and prednisolone (5-10 mg per day).
The blood serum levels of IL-2, IL-6, IL-8
The levels of IL-2, IL-6 and IL-8 were tested with ELISA Quantikine Human Interleukin Immunoassay (R&D Systems). The lowest levels detection levels of IL-2, IL-6 and IL-8 were 7.0, 0.7 and 10 pg/cm 3 , respectively. Blood samples were drawn from antecubital veins on a fasting basis.
Statistical analysis
The results are expressed as arithmetic mean ± standard deviation in MFI (mean fluorescence intensity) units. The differences were analyzed with Mann-Whitney U test. The significance levels in all cases was at p<0.05.
Results
The initial six-month follow-up demonstrated a tendency of blood serum increase of IL-2 if compared to the baseline levels but this increase was not significant. After another six-month time period there was also an insignificant decrease in these levels. The initial blood serum levels of IL-6 were decreased during the first and the consecutive follow-up period and it also appeared statistically insignificant. Furthermore, there was only a tendency of IL-8 to decrease, accompanied by insignificant increases after a twelve month time period ( Table 2 ).
Discussion
Beside dialysis is renal transplantation, the possible renal replacement therapy available in the end stage of chronic renal failure. This option is however related to immune complications elicited by the alien antigens and is accompanied by self-propelling immune responses of the rejection of transplanted tissues; this involves cellular [9, 10] . The multiple sites of biological action of cytokines in the course of transplantation reaction appeared a useful tool for graft rejection monitoring and immunosuppressive therapy which was specifically aimed to cytokines and the cytokine receptors [12] . The reliability of circulating IL-8 levels was demonstrated in monitoring RT patients [13] , whereas other data indicated a superior index value of urine levels of IL-8 if compared with the peripheral blood serum for the purpose of rejection monitoring [14] . IL-6 was reportedly the most sensitive index of graft rejection in RT patients [15] [16] [17] [18] [19] . The current study demonstrated constant blood serum levels of IL-2, IL-6 and IL-8 within an eighteen month follow-up time period in RT patients that may be related to appropriate dose of immune suppressive therapy and adequate tolerance of the graft tissue ( Table 2) . Although the mechanisms underlying cellular and immune interactions in RT patients remain elucidated, the available data might reflect the chronic inflammatory reactions associated with graft rejection.
